Back to top

Novocure resumed with a Neutral at JPMorgan

JPMorgan resumed coverage of Novocure (NVCR) with a Neutral rating and $17 price target The firm believes the shares already price in credit for th...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

NovoCure Limited (NVCR)